Literature DB >> 3092610

Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature.

T F Barkve, K Langseth-Manrique, J E Bredesen, K Gjesdal.   

Abstract

In a study of GTN absorption during exercise and high ambient temperature, 12 healthy volunteers carried 10 mg glyceryl trinitrate (GTN, nitroglycerin) transdermal patches for 6 hours during each of 3 days. During a control day the mean plasma GTN concentration ranged from 1.0 nmol/L (SD +/- 0.8 nmol/L) to 1.5 nmol/L (SD +/- 1.0 nmol/L), whereas during a bicycle ergometer day mean GTN concentration was increased to 3.1 nmol/L (SD +/- 1.7 nmol/L, p less than 0.001). During a sauna day volunteers stayed for 20 minutes in a sauna, and mean GTN concentration in plasma rose to 7.3 nmol/L (SD +/- 1.7 nmol/L, p less than 0.001). Systolic blood pressure increased during exercise (p less than 0.01) but decreased significantly in the sauna (p less than 0.01). Headache was noted frequently (9 of 12 subjects) and dizziness by a few (3 of 12). The demonstrated increased transdermal absorption in our study may infer an increased effect during workload. Whereas the increase in transdermally absorbed GTN may be beneficial to the exercising angina patient, increased effects of GTN may be undesirable in hot surroundings. A study on angina patients is justified to assess whether this phenomenon bears clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092610     DOI: 10.1016/0002-8703(86)90518-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin.

Authors:  T O Klemsdal; K Gjesdal; J E Bredesen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Effect of local controlled heat on transdermal delivery of nicotine.

Authors:  Kristian Kjær Petersen; Mark Lillelund Rousing; Carina Jensen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-08

3.  The effect of transdermal nitroglycerin on exercise tolerance in relation to patch application time--a meta-analysis.

Authors:  T O Klemsdal; K Gjesdal
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

4.  The effect of topical capsaicin-induced sensitization on heat-evoked cutaneous vasomotor responses.

Authors:  Thomas A Nielsen; Larissa Bittencourt da Silva; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

5.  Transdermal patch drug delivery interactions with exercise.

Authors:  Thomas L Lenz; Nicole Gillespie
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

Review 6.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 7.  Intermittent or continuous transdermal nitroglycerin: still an issue, or is the case closed?

Authors:  T O Klemsdal; K Gjesdal
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

Review 8.  Heat exposure and drugs. A review of the effects of hyperthermia on pharmacokinetics.

Authors:  J Vanakoski; T Seppälä
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

10.  Transdermal nitrate therapy: bioavailability during exercise increases transiently after the daily change of patch.

Authors:  K Gjesdal; T O Klemsdal; E O Rykke; J E Bredesen
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.